Cue Biopharma, Inc. (CUE)
NASDAQ
Cue Biopharma, Inc. annual/quarterly shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Cue Biopharma, Inc. shareholder equity for the quarter ending December 31, 2025 were 26.4M, a 51.05% increase year-over-year.
- Cue Biopharma, Inc. shareholder equity for 2025 were 26.4M, a 51.05% increase from 2024.
- Cue Biopharma, Inc. shareholder equity for 2024 were 17.5M, a 52.81% decrease from 2023.
- Cue Biopharma, Inc. shareholder equity for 2023 were 37.1M, a 43.54% decrease from 2022.
- Cue Biopharma, Inc. shareholder equity for 2022 were 65.7M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cue Biopharma, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $26 |
| 2024 | $17 |
| 2023 | $37 |
| 2022 | $66 |
| 2021 | $65 |
| 2020 | $79 |
| 2019 | $55 |
| 2018 | $34 |
| Cue Biopharma, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $26 |
| 2024-12-31 | $17 |
| 2023-12-31 | $37 |
| 2022-12-31 | $66 |
| 2021-12-31 | $65 |
| 2020-12-31 | $79 |
| 2019-12-31 | $55 |
| 2018-12-31 | $34 |
Cue Biopharma, Inc. Shareholder Equity — FAQ
Cue Biopharma, Inc. (CUE) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CUE's shareholder equity history?
The chart and table above show Cue Biopharma, Inc.'s shareholder equity by year and by quarter, including the growth rate.